Get started
Author

Crystal C. Lipsey

Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer
2016 · Crystal C Lipsey, Adriana Harbuzariu, et al. · World Journal of Methodology · 96
PDF
Leptin-Notch signaling axis is involved in pancreatic cancer progression
2016 · Adriana Harbuzariu, Antonio Rampoldi, et al. · Oncotarget · 73
PDF
Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation
2016 · Viola Lanier, Corey Gillespie, et al. · The International Journal of Biochemistry & Cell Biology · 45
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
2020 · Crystal C. Lipsey, Adriana Harbuzariu, et al. · International Journal of Molecular Sciences · 26
PDF
Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer
2017 · Tia Harmon, Adriana Harbuzariu, et al. · World Journal of Clinical Oncology · 26
PDF
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance
2023 · George Alyateem, Heidi M. Wade, et al. · Cancer Gene Therapy · 20
PDF
The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2023 · Robert W. Robey, Christina M. Fitzsimmons, et al. · Molecular Cancer Therapeutics · 17
PDF
Small-molecule screening identifies Syk kinase inhibition and rutaecarpine as modulators of macrophage training and SARS-CoV-2 infection
2022 · Sinu P. John, Anju Singh, et al. · Cell Reports · 14
Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and Their Zebrafish Homologs at the Blood-Brain Barrier
2024 · John A. Quinlan, Sashank Sabbineni, et al. · Molecular Pharmacology · 2
PDF
Abstract C52: Targeting the obesity/leptin link to TNBC: A breast cancer disparity problem
2016 · Courtney D. Dill, Adriana Harbuzariu, et al. · Cancer Epidemiology Biomarkers & Prevention · 1
Variation in Mitochondrial Bioenergetics and Reactive Species Production May Contribute to Racial Differences in Cardiovascular Disease Susceptibility
2010 · David M Krzywanski, David G Westbrook, et al. · Free Radical Biology and Medicine · 1
Figure S6 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Figure S5 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Supplemental Table S6 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Supplemental Table S3 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Supplemental Table S7 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Supplemental Table S5 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Supplemental Table S1 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Supplemental Table S2 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Supplemental Table S4 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Supplemental Table S8 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Figure S1 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Figure S3 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Figure S2 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Figure S4 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
2026 · Robert W. Robey, Christina M. Fitzsimmons, et al.
Works count: 55
Citation count: 321
H-index: 8
I10-index: 8
Year
Topic
Type